/Companies

Neurolutions

Van Nuys, US · Delaware corporation · 102 employees on LinkedIn · 3 known investors

Find your way into Neurolutions

Each arrow is one introduction. Sign up to fill in the first one.

313 people can intro you to Eric

Ask Avichay Nissenbaum to introduce you to Eric Leuthardt

You →Avichay · together at Inner Cosmos →Eric

8 people can intro you to Leo

Ask Jamie Chen to introduce you to Leo Petrossian

You →Jamie · together at Nile →Leo

Sign up to find every way you can get introduced to Neurolutions

  • Your email: who you already know at Neurolutions, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Neurolutions team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Neurolutions makes IpsiHand, an FDA-cleared brain-computer interface system for at-home motor rehabilitation of chronic stroke survivors with arm and hand weakness. The system pairs a non-invasive EEG headset, a thought-controlled wireless handpiece, and a tablet to guide and track therapy.

Founders & leadership

ELEric Leuthardt
Eric LeuthardtCo-Founder, Chief Scientific Officer, and Board MemberEric Leuthardt is a physician-innovator and Director of the Center for Innovation in Neuroscience and Technology at Washington University, with extensive experience in medical technology, neurotechnology entrepreneurship, and brain-computer interface development; he holds numerous patents and publications in neuroscience and has founded companies including Neurolutions.
LPLeo Petrossian
Leo PetrossianChief Executive Officer and Board DirectorLeo Petrossian is a MedTech executive who has led multiple neurotechnology and brain-computer interface companies through FDA authorization, CMS reimbursement, and commercialization, with background spanning non-invasive BCI therapy, AI-enabled medical devices, and digital health.

Board

YT
Yuanwei TaiBoard director
KRKevin Reilly
Kevin ReillyBoard MemberManaging Director and Head of MedTech Investments at Ally Bridge Group
FKFred Khosravi
Fred KhosraviExecutive ChairmanChairman & Co-Founder at Tulavi Therapeutics
SV
Stavros VizirgianakisBoard director
AS
Amarpreet SawhneyBoard director

Investors · 3

Reported raises · per SEC filings

Form D private placements

$26.5M disclosed across 1 round · 2025

▶$26.5MraisedMar 2025 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Leo PetrossianExecutive Officer, Director
  • Yuanwei TaiDirector
  • Kevin ReillyDirector
  • Stavros VizirgianakisDirector
  • Amarpreet SawhneyDirector
  • Fred KhosraviDirector
  • Eric LeuthardtDirector
Offering amount
$42.8M
Amount sold
$26.5M
First sale
Feb 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

3 people who came through Neurolutions went on to found or lead other companies.

Related companies · 2

Companies working in the same space as Neurolutions.

In the news

Frequently asked questions

What does Neurolutions do?
Neurolutions makes IpsiHand, an FDA-cleared brain-computer interface system for at-home motor rehabilitation of chronic stroke survivors with arm and hand weakness. The system pairs a non-invasive EEG headset, a thought-controlled wireless handpiece, and a tablet to guide and track therapy.
Who founded Neurolutions?
Neurolutions was founded by Eric Leuthardt.
Who are Neurolutions's investors?
Neurolutions's investors include Excelestar Ventures, Ally Bridge Group, Amed Ventures.
How much funding has Neurolutions raised?
Neurolutions has disclosed $26.5M raised across 1 round.
Where is Neurolutions headquartered?
Neurolutions is headquartered in Van Nuys, US.